View of CLINICAL OUTCOMES OF NEOADJUVANT CONCURRENT CHEMORADIOTHERAPY USING VOLUMETRIC MODULATED ARC THERAPY IN PATIENTS WITH STAGE II-IVA MIDDLE AND LOWER THORACIC ESOPHAGEAL CANCER

Return to Issue Details CLINICAL OUTCOMES OF NEOADJUVANT CONCURRENT CHEMORADIOTHERAPY USING VOLUMETRIC MODULATED ARC THERAPY IN PATIENTS WITH STAGE II-IVA MIDDLE AND LOWER THORACIC ESOPHAGEAL CANCER Download Download PDF